Skip to main content

Table 2 Biosynthesis of metallic NPs using various bacteria and their biomedical applications

From: Biogenic metallic nanoparticles as game-changers in targeted cancer therapy: recent innovations and prospects

MNPs/MONPs

Bacteria used

Metal precursor used

Morphology

Biomedical applications

Findings

References

CuO

Marine endophytic Actinomycetes CKV1

Copper (II) sulfate pentahydrate

Spherical shape

10–30 nm

Antibacterial, anticancer, antibiofilm activity

At 750 µg/mL, CuO NPs showed remarkable antibacterial activity against E. Coli and P. mirabilis, exhibiting 24 mm and 28 mm zones. At 500 µg/mL, 54% inhibition was recorded against A549 cells

[127]

Streptomyces sp. MHM38

Copper (II) sulfate

Spherical

1.72–13.49 nm

Antimicrobial

CuO nanoparticles showed antibacterial efficacy against Enterococcus faecalis, Salmonella typhimurium, E. coli, P. aeruginosa, and Candida albicans

[128]

Marinomonas Rhodococcus Pseudomonas Brevundimonas

Bacillus

Copper (II) sulfate pentahydrate

Spherical/ovoidal shapes

40 nm

Antibacterial, antifungal

The MIC of CuO NPs ranged from 3.12 to 25 µg/mL for Gram-negative bacteria, 12.5 to 25 µg/mL for Gram-positive bacteria, and 12.5 to 25 µg/mL for fungi

[129]

Actinomycetes

Copper (II) sulfate pentahydrate

Crystalline

198 nm

Antibacterial

B. cereus showed high susceptibility (25.3 mm) to CuO NPs. The CuO NPs inhibited bacterial pathogens B. cereus, P. mirabilis, and A. caviae at 5 µg/mL

[130]

ZnO

Cyanobacterium Nostoc sp. EA03

Zinc acetate dihydrate

Star-like shape

50–80 nm

Antibacterial, anticancer activity

MIC and MBC values for E. coli, P. aeruginosa, and S. aureus were found to be 2000, 2000, and 64 µg/mL, and 2500, 2500, and 128 µg/mL, respectively. ZnO NPs were less cytotoxic to MRC-5 lung fibroblast cells than to A549 cells treated with cancer

[131]

Paraclostridium benzoelyticum strain 5610

Zinc nitrate

Spherical/rectangular shape

50 nm

Antibacterial, anti-inflammatory, antidiabetic

Inhibitory zone of Helicobacter suis measured 19.53 ± 0.62 mm at 5 mg/mL. After 21 days. In arthritis model the edema was inhibited by NPs by 87.62 ± 0.12%. ZnO NPs sharply reduced glucose level in STZ-induced diabetic mice

[132]

B. subtilis ZBP4

Zinc sulfate heptahydrate

Pseudo-spherical

14–45 nm

Antibacterial

For B. cereus, S. aureus, E. coli O157:H7, E. coli Type 1, and P. aeruginosa the MIC was 1 mg/mL. It was 2 mg/mL for L. monocytogenes and S. typhimurium

[133]

Saccharomyces cerevisiae

Zinc acetate dihydrate

Spherical

20–30 nm

Antioxidant, antibacterial, anticancer, photocatalytic activity

ZnO NPs showed concentration-dependent increases in anti-cancer activity. At 100 µg/mL, ZnO NPs inhibited 93% cells

[134]

TiO2

B. subtilis

Titanium dioxide

Spherical

70.17 nm

Treatment of dental caries

Dental caries responded best to treatment with 5% TiO2, which had no discernible cytotoxic effects

[135]

Rummelii pycnus

Acinetobacter baumanii Acinetobacter seohaensis

Bacillus cereus

Titanium Oxychloride

Spherical/irregular

8 nm

Antibacterial

Maximum zone of inhibition was found at 50 mL of TiO2 NPs

[136]

Streptomyces sp. HC1

Titanium oxyhydroxide

Spherical

30–70 nm

Antimicrobial, antibiofilm

The highest level of antibiofilm activity was shown by 500 μL TiO2 NPs produced by Streptomyces sp. HC1. Maximum zone of inhibition was recorded against S. aureus and E. coli

[137]

Ag

Streptomyces rochei MS-37

Silver nitrate

Spherical

23.2 nm

Antibacterial, anti-inflammatory, antioxidant

Ag NPs had IC50 value of 34.03 µg/mL in CAL27 and 81.16 µg/mL in human peripheral blood mononuclear cells, indicating CAL27 was more susceptible to the NPs cytotoxicity. Ag NPs had MIC ranging from 8 to 128 µg/mL

[138]

Streptomyces parvus

Silver nitrate

9.7–17.25 nm

Antimicrobial, antioxidant

K. pneumoniae (28.33 mm) and E. coli (21.66 mm) were susceptible to antibacterial activity. When compared to E. faecalis (125 μg/mL), S. aureus (250 μg/mL), P. aeruginosa (125 μg/mL), K. pneumoniae (500 μg/mL), and E. coli (250 μg/mL), the MIC of Ag NPs was significant

[139]

Nocardiopsis dassonvillei

Silver nitrate

Spherical

29.28 ± 2.2 and 32.13 ± 3.4 nm

Antimicrobial, antioxidant, anticancer

Ag NPs showed notable scavenging activity with IC50 values of 4.08 and 8.9 µg/mL against OH and DPPH radicals, respectively. Ag NPs with CaCo2 cells demonstrated concentration dependent reduction in cell viability. Lactate dehydrogenase leakage increased as cell viability declined

[140]

Bacillus amyloliquefaciens MSR5

Silver nitrate

Spherical/cubical/and regular

29.2 nm

Anticancer, catalytic activity

Using NaBH4, Ag NPs demonstrated potent chemocatalytic action, completely degrading 4-NP to 4-aminophenol (4-AP) in 15 min. Ag NPs activated A549cells

[141]

Bacillus brevis (NCIM 2533)

Silver nitrate

Spherical

41 nm

Antibacterial

Ag NPs demonstrated mean zone of inhibition 14, 15, 16, and 19 mm against S. aureus at 5, 10, 15, and 20 μL

[142]

Au

Streptomyces sp.

NH21

Chloroauric acid

Spherical/rod

18–20 nm

Antibacterial

Ag NPs had MIC of 2.5 µg/mL against E. coli, 5 µg/mL against K. pneumoniae, P. mirabilis, and S. infantis, and 10 µg/mL against P. aeruginosa and B. subtilis. For P. aeruginosa and B. subtilis minimum bactericidal concentrations were 140 and 170 µg/mL

[143]

Vibrio alginolyticus

Chloroauric acid

100–150 nm

Antioxidant, anticancer

Colon cancer cell growth inhibited by Au NPs in a dose-dependent manner. 25 µg/mL resulted in maximum inhibition of cell death (> 75%), with an IC50 of 15 µg/mL

[144]

Paracoccus haeundaensis BC74171T

Chloroauric acid

Spherical

20.93 ± 3.46 nm

Antioxidant, anticancer

In HaCaT and HEK293 normal cells, Au NPs did not exhibit growth inhibition. Au NPs exhibited concentration dependent growth inhibition against A549 and AGS cancer cells

[145]

Enterococcus sp. RMAA

Gold chloride

Spherical

Anticancer

Mitochondrial membrane potential was lowered, ROS and caspase-3 expressions were increased

[146]